Literature DB >> 27681425

Divergent Expression and Metabolic Functions of Human Glucuronosyltransferases through Alternative Splicing.

Michèle Rouleau1, Alan Tourancheau1, Camille Girard-Bock1, Lyne Villeneuve1, Jonathan Vaucher2, Anne-Marie Duperré1, Yannick Audet-Delage1, Isabelle Gilbert1, Ion Popa2, Arnaud Droit2, Chantal Guillemette3.   

Abstract

Maintenance of cellular homeostasis and xenobiotic detoxification is mediated by 19 human UDP-glucuronosyltransferase enzymes (UGTs) encoded by ten genes that comprise the glucuronidation pathway. Deep RNA sequencing of major metabolic organs exposes a substantial expansion of the UGT transcriptome by alternative splicing, with variants representing 20% to 60% of canonical transcript expression. Nearly a fifth of expressed variants comprise in-frame sequences that may create distinct structural and functional features. Follow-up cell-based assays reveal biological functions for these alternative UGT proteins. Some isoforms were found to inhibit or induce inactivation of drugs and steroids in addition to perturbing global cell metabolism (energy, amino acids, nucleotides), cell adhesion, and proliferation. This work highlights the biological relevance of alternative UGT expression, which we propose increases protein diversity through the evolution of metabolic regulators from specific enzymes.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucuronosyltransferase (UGT); RNA sequencing; alternative splicing; cell metabolism; drug metabolism; glucuronidation; transcriptome

Mesh:

Substances:

Year:  2016        PMID: 27681425     DOI: 10.1016/j.celrep.2016.08.077

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  7 in total

1.  Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues.

Authors:  A Tourancheau; M Rouleau; S Guauque-Olarte; L Villeneuve; I Gilbert; A Droit; C Guillemette
Journal:  Pharmacogenomics J       Date:  2017-04-25       Impact factor: 3.550

2.  Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Authors:  Adrien Labriet; Eric P Allain; Michèle Rouleau; Yannick Audet-Delage; Lyne Villeneuve; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2018-02-09       Impact factor: 3.922

3.  Alternative transcript splicing regulates UDP-glucosyltransferase-catalyzed detoxification of DIMBOA in the fall armyworm (Spodoptera frugiperda).

Authors:  Bhawana Israni; Katrin Luck; Samantha C W Römhild; Bettina Raguschke; Natalie Wielsch; Yvonne Hupfer; Michael Reichelt; Aleš Svatoš; Jonathan Gershenzon; Daniel Giddings Vassão
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

4.  Endogenous Protein Interactome of Human UDP-Glucuronosyltransferases Exposed by Untargeted Proteomics.

Authors:  Michèle Rouleau; Yannick Audet-Delage; Sylvie Desjardins; Mélanie Rouleau; Camille Girard-Bock; Chantal Guillemette
Journal:  Front Pharmacol       Date:  2017-02-03       Impact factor: 5.810

5.  Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families.

Authors:  Fan Yang; Sijie Liu; Gerhard Wolber; Matthias Bureik; Maria Kristina Parr
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

6.  Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets.

Authors:  Dinesh Kumar Barupal; Oliver Fiehn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

Review 7.  Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression.

Authors:  Eric P Allain; Michèle Rouleau; Eric Lévesque; Chantal Guillemette
Journal:  Br J Cancer       Date:  2020-02-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.